Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Generic Drug Industry Scandal: Convicted FDA Reviewer Is Freed From Debarment

This article was originally published in The Pink Sheet Daily

Executive Summary

Twenty-five years after he pled guilty to taking payments from companies, former FDA review chemist David Brancato gets FDA to terminate his debarment; several industry execs won terminations years ago.

Advertisement

Related Content

Insider Trading Bull's-Eye: FDA Chemist Charged With Using Agency's DARRTS NDA Tracking System For Improper Trades

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register